Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,814
Total Claims
$1.6M
Drug Cost
250
Beneficiaries
$6,263
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+487%
Cost per patient vs peers
$6,263 vs $1,068 avg
+148%
Brand preference vs peers
22.3% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 2,365 claims · $1.3M
Generic: 8,232 claims · $275K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 471 | $198K |
| Empagliflozin | 153 | $139K |
| Apixaban | 209 | $134K |
| Lipase/Protease/Amylase | 105 | $109K |
| Sitagliptin Phos/Metformin Hcl | 120 | $102K |
| Sitagliptin Phosphate | 119 | $78K |
| Omeprazole/Sodium Bicarbonate | 28 | $65K |
| Linaclotide | 92 | $53K |
| Sacubitril/Valsartan | 63 | $46K |
| Dexlansoprazole | 150 | $39K |
| Dapagliflozin Propanediol | 62 | $38K |
| Diclofenac Sodium | 103 | $28K |
| Insulin Degludec | 38 | $27K |
| Fluticasone Propion/Salmeterol | 57 | $22K |
| Semaglutide | 20 | $22K |
Prescribing Profile
Patient Profile
74
Avg Age
52%
Female
1.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data